Page last updated: 2024-09-04

rhodioloside and on 01210.na

rhodioloside has been researched along with on 01210.na in 1 studies

Compound Research Comparison

Studies (rhodioloside)	Trials (rhodioloside)	Recent Studies (post-2010) (rhodioloside)	Studies (on 01210.na)	Trials (on 01210.na)	Recent Studies (post-2010) (on 01210.na)
621	2	519	14	0	12

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, H; Cui, J; Feng, T; Jing, J; Liu, C; Wang, L; Wang, S; Wu, R; Zhang, S; Zhou, N	1

Other Studies

1 other study(ies) available for rhodioloside and on 01210.na

Article	Year
Salidroside, a scavenger of ROS, enhances the radioprotective effect of Ex-RAD® via a p53-dependent apoptotic pathway. Oncology reports, 2017, Volume: 38, Issue:5 Topics: Animals; Apoptosis; DNA Damage; Drug Synergism; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Mice; Phenols; Radiation-Protective Agents; Reactive Oxygen Species; Sulfonamides; Survival Rate; Tumor Suppressor Protein p53	2017

Article

Year

Salidroside, a scavenger of ROS, enhances the radioprotective effect of Ex-RAD® via a p53-dependent apoptotic pathway.

Oncology reports, 2017, Volume: 38, Issue:5

Topics: Animals; Apoptosis; DNA Damage; Drug Synergism; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Mice; Phenols; Radiation-Protective Agents; Reactive Oxygen Species; Sulfonamides; Survival Rate; Tumor Suppressor Protein p53

2017